Hemophilia A Clinical Trials in Beijing, Beijing Municipality
5 recruitingBeijing, Beijing Municipality, China
Showing 1–5 of 5 trials
Recruiting
Phase 2Phase 3
Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs
Hemophilia A
Shanghai Xinzhi BioMed Co., Ltd.55 enrolled10 locationsNCT06111638
Recruiting
Phase 3
Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products
Congenital Hemophilia A
CSL Behring60 enrolled20 locationsNCT06738485
Recruiting
Phase 3
To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A
Hemophilia A
Gritgen Therapeutics Co., Ltd.50 enrolled13 locationsNCT06833983
Recruiting
Phase 4
Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)
Hemophilia A With Inhibitor
Runhui WU110 enrolled1 locationNCT06864975
Recruiting
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
ThrombophiliaThrombosisArterial Thromboembolism+13 more
Peking University People's Hospital3,000 enrolled5 locationsNCT06727669